The Optical Detection Biosensors segmentation by Application is dominated by four principal uses. Clinical diagnostics—including point‑of‑care testing, hospital laboratory assays, and personalized medicine—accounts for roughly 45 % of total revenue, driven by high volume testing and reimbursement structures. Environmental monitoring—covering water quality, air‑borne pollutant detection, and soil analysis—contributes about 30 % as regulatory mandates increase and real‑time sensing becomes cost‑effective. Food safety applications—such as pathogen screening, allergen detection, and freshness monitoring—represent an estimated 15 % of the market, reflecting rising consumer safety standards and supply‑chain transparency. The remaining 10 % stems from Research & Development activities, where academic and corporate labs employ optical biosensors for biomarker discovery, assay validation, and prototype development. Each application segment influences the overall market size by dictating required sensitivity, integration complexity, and production volume, thereby shaping investment priorities across the optical biosensor ecosystem.